Cresco Labs Inc. (CRLBF) Notes Payables (2019 - 2025)

Cresco Labs (CRLBF) has reported Notes Payables for 6 consecutive years, with $10.8 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables fell 9.64% year-over-year to $10.8 million; the trailing twelve-month figure through Dec 2025 stood at $10.8 million (down 9.64% YoY), and the FY2025 full-year result was $10.8 million, down 9.64% from the prior year.
• Notes Payables climbed to $10.8 million in Q4 2025 per CRLBF's latest filing, from $9.8 million in the prior quarter.
• Across five years, Notes Payables topped out at $29.2 million in Q1 2022 and bottomed at $9.8 million in Q3 2025.
• Historically, Notes Payables has averaged $19.8 million across 5 years, with a median of $20.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Notes Payables surged 86.77% in 2022, then tumbled 56.01% in 2025.
• Over 5 years, Notes Payables stood at $15.4 million in 2021, then soared by 86.77% to $28.8 million in 2022, then slipped by 3.69% to $27.8 million in 2023, then plunged by 57.05% to $11.9 million in 2024, then decreased by 9.64% to $10.8 million in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $10.8 million, $9.8 million, and $12.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.